DRG Epidemiology’s coverage of Essential Thrombocythemia comprises epidemiological estimates of key patient populations in the major mature pharmaceutical markets (the United States, France,…
DRG Epidemiology’s coverage of polycythemia vera comprises epidemiological estimates of key patient populations in the major mature pharmaceutical markets (the United States, France, Germany,…
DRG Epidemiology's coverage of traumatic brain injury (TBI) comprises epidemiological estimates of key patient populations in the major mature pharmaceutical markets (United States, France,…
The number of prevalent cases of uterine fibroids in the countries under study will remain relatively stable over the 20-year forecast period. Of the countries considered in this analysis, the…
Clarivate Epidemiology's coverage of coronary heart disease (CHD) comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report both the incidence and…
Clarivate Epidemiology's coverage of coronary heart disease (CHD) comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report both the incidence and…
Clarivate Epidemiology's coverage of coronary heart disease (CHD) comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report both the incidence and…
Clarivate’s Extrapolated Worldwide Coverage is the first and only evidence-based data set of epidemiological forecasts for key Coronary Heart Disease patient populations covering 171 countries…
Clarivate Epidemiology's coverage of coronary heart disease (CHD) comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report both the incidence and…
Clarivate Epidemiology's coverage of coronary heart disease (CHD) comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report both the incidence and…
Clarivate Epidemiology's coverage of schizophrenia comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report the prevalence of schizophrenia for…
Clarivate Epidemiology's coverage of schizophrenia comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report the prevalence of schizophrenia for…
Clarivate Epidemiology's coverage of schizophrenia comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report the prevalence of schizophrenia for…
Clarivate Epidemiology's coverage of schizophrenia comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report the prevalence of schizophrenia for…
Clarivate Epidemiology's coverage of schizophrenia comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report the prevalence of schizophrenia for…
